What is the recommended dose of Chloroquine (Chloroquine phosphate) for uncomplicated malaria?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Chloroquine Dosing for Uncomplicated Malaria

For uncomplicated malaria caused by chloroquine-sensitive species, administer chloroquine phosphate 1000 mg salt (600 mg base) initially, followed by 500 mg salt (300 mg base) at 6,24, and 48 hours, for a total dose of 2500 mg salt (1500 mg base) or 25 mg/kg over 3 days. 1, 2

Species-Specific Dosing

P. vivax, P. ovale, P. malariae, and P. knowlesi

Adult dosing:

  • Initial dose: 1000 mg salt (600 mg base) at hour 0
  • Second dose: 500 mg salt (300 mg base) at 6 hours
  • Third dose: 500 mg salt (300 mg base) at 24 hours
  • Fourth dose: 500 mg salt (300 mg base) at 48 hours
  • Total cumulative dose: 2500 mg salt (1500 mg base) or 25 mg/kg 1, 3, 2

Pediatric dosing:

  • Initial dose: 10 mg base/kg at hour 0 (maximum 600 mg base)
  • Second dose: 5 mg base/kg at 6 hours (maximum 300 mg base)
  • Third dose: 5 mg base/kg at 24 hours
  • Fourth dose: 5 mg base/kg at 36 hours
  • Total cumulative dose: 25 mg base/kg 3, 4, 2

P. falciparum

Chloroquine is NOT recommended as first-line treatment for P. falciparum in most regions due to widespread resistance. 1 However, in the rare chloroquine-sensitive areas, use the same dosing regimen as above. 1

Critical Considerations

Formulation Differences

  • Chloroquine phosphate tablets contain 500 mg salt = 300 mg base
  • Chloroquine sulfate tablets contain 200 mg salt = 150 mg base, requiring 6 tablets initially, then 3 tablets at 6,24, and 48 hours 1
  • Always verify which formulation you are prescribing to avoid underdosing

Geographic Resistance Patterns

  • Chloroquine-resistant P. vivax occurs in Papua New Guinea and Indonesia; use artemisinin-based combinations instead 1
  • P. falciparum in Southeast Asia and most of sub-Saharan Africa is chloroquine-resistant 1, 5

Special Populations

Pregnancy:

  • Use standard adult chloroquine dosing—chloroquine is safe in all trimesters 1, 4, 5
  • Do not withhold treatment due to pregnancy 4

Renal failure:

  • No dose adjustment needed, even in dialysis patients, as chloroquine is primarily hepatically metabolized 5

Radical Cure for P. vivax and P. ovale

  • Must add primaquine 30 mg base daily for 14 days (adults) or 0.3 mg/kg/day for 14 days (children) to eradicate hypnozoites 1, 3
  • Check G6PD status before primaquine—contraindicated in severe G6PD deficiency due to hemolysis risk 1, 3

Monitoring and Follow-up

  • Directly observe all doses when possible to ensure adherence 3, 4
  • Repeat thick blood smear if symptoms persist beyond 3 days 3, 4
  • Switch to alternative therapy if parasitemia has not decreased markedly by day 3 3, 4

Common Pitfalls

Underdosing in children: Age-based dosing regimens commonly used in endemic areas (dispensing in plastic bags) lead to suboptimal dosing in 30-64% of children, particularly younger patients. 6 Always calculate dose by weight, not age.

Assuming malaria is the only cause of fever: The presence of Plasmodium on blood smear does not exclude other causes such as pneumonia, meningitis, or acute respiratory infections—evaluate and treat accordingly. 3, 4

Using chloroquine in resistance areas: This leads to treatment failure and potentially fatal outcomes. 5 Verify local resistance patterns before prescribing.

Adverse Effects

  • Common: Nausea, vomiting, pruritus, postural hypotension 1
  • Cardiovascular: QTc prolongation can occur but is generally well-tolerated at standard doses 7
  • Higher doses (50-70 mg/kg) are well-tolerated in children but show similar QTc prolongation to standard dosing 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Antimalarial Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Chloroquine Treatment for Plasmodium Malariae Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Chloroquine Prophylaxis Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.